skip to primary navigationskip to content
 

Dr Elizabeth Bilsland


Office Phone: 01223 333662

Key Publications

  • Viol M.A., Bilsland E., da Silveira Neto L., Coelho W.M.D., Loyola S.N., de Aquino M.C.C., Bresciani K.D.S. (2014) Considerations about visceral leishmaniasis and its control. Main Canine Protozoan Zoonosis. Nova Publishers, New York, ISBN: 978-1-63117-384-4.
  • Favrin G., Bean D.M., Bilsland E., Boyer H., Fischer B., Russell S., Crowther D.C., Oliver S.G., Baylis H.A., Giannakou M.E. (2013) Identification of novel modifiers of Aβ toxicity by transcriptomic analysis in the fruitfly. Scientific Reports 3, article number 3512.
  • Bilsland E.*, Sparkes A.*, Williams K., Moss H.J., de Clare M., Pir P., Rowland J., Aubrey W., Pateman R., Young M., Carrington M., King R.D. & Oliver S.G. (2013) Yeast-based automated high-throughput screens to identify anti-parasitic lead compounds. Open Biol.. 20133:120158; doi:10.1098/rsob.120158.
  • Kell D.B., Dobson P.D., Bilsland E. & Oliver S.G. (2012) The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so. Drug Discov Today. 2012 Nov 30. doi:pii: S1359-6446(12)00394-7. 10.1016/j.drudis.2012.11.008.
  • Bilsland E., Pir P. , Gutteridge A., Johns A., King S.D., Oliver S.G. (2011) Functional expression of parasite drug targets and their human orthologs in yeast. Plos Neglected tropical Diseases 5(10):e1320.
  • Lanthaler K.*, Bilsland E.*, Dobson P.D., Moss H.J., Pir P., Kell D.B. & Oliver S.G. (2011) Genome-wide assessment of the carriers involved in the cellular uptake of drugs: a model system in yeast.  BMC Biology 9(1):70.*equal author contribution
  • Zhang N. and Bilsland E. (2011) Contributions of Saccharomyces cerevisiae to understanding mammalian gene function and therapy. In, Castrillo J. I. and Oliver S. G., Eds. 'Yeast Systems Biology. Methods and Protocols'. Methods in Molecular Biology (MiMB) series. Vol. 759. (Series Ed: Walker, John M. ISSN: 1064-3745) pp. 501-23. Humana Press. Springer, New York.
  • Cvijovic M., Dalevi D., Bilsland E., Kemp G.J., Sunnerhagen P. (2007) Identification of putative regulatory upstream ORFs in the yeast genome using heuristics and evolutionary conservation. BMC Bioinformatics 8: 295.
  • Bilsland E., Hult M., Bell S.D., Sunnerhagen P., Downs J.A. (2007) The Bre5/Ubp3 ubiquitin protease complex from budding yeast contributes to the cellular response to DNA damage. DNA Repair (Amst) 6: 1471-1484.
  • Bilsland E., Downs J.A. (2005) Tails of histones in DNA double-strand break repair. Mutagenesis 20: 153-163.
  • Bilsland E., Molin C., Swaminathan S., Ramne A., Sunnerhagen P. (2004) Rck1 and Rck2 MAPKAP kinases and the HOG pathway are required for oxidative stress resistance. Mol Microbiol 53: 1743-1756.
  • Bilsland-Marchesan E., Arino J., Saito H., Sunnerhagen P., Posas F.(2000) Rck2 kinase is a substrate for the osmotic stress-activated mitogen-activated protein kinase Hog1. Mol Cell Biol 20: 3887-3895.
  • Ramne A.*, Bilsland-Marchesan E.*, Erickson S., Sunnerhagen P. (2000) The protein kinases Rck1 and Rck2 inhibit meiosis in budding yeast. Mol Gen Genet 263: 253-261.*equal author contribution
  • Bilsland E., Dahlen M., Sunnerhagen P. (1998) Genomic disruption of six budding yeast genes gives one drastic example of phenotype strain-dependence. Yeast 14, 655-664.